Patent 9181572 was granted and assigned to AbbVie Inc. on November, 2015 by the United States Patent and Trademark Office.
The instant invention relates to the field of protein production and purification, and in particular to compositions and processes for controlling the distribution or amount of lysine variants expressed by host cells, as well as to compositions and processes for controlling the amount of lysine variants present in purified preparations.